InvestorsHub Logo
Followers 207
Posts 17343
Boards Moderated 2
Alias Born 01/12/2012

Re: ZeWaffleBaron post# 810

Thursday, 10/12/2017 10:02:52 PM

Thursday, October 12, 2017 10:02:52 PM

Post# of 1954
I liked this article with a Biotech Investor Avisol Biotech Partners , thought I would share it because it is very informative analysis on picking Biotech stocks.

"We value development stage biotech companies on six metrics - management, pipeline, market, IP, partnerships, cash position."

"SA: Do you prefer to enter biotech companies at a certain phase (For example, companies with products in their pipelines that have passed Stage II trials and are moving to Stage III)? If so, how have you come to this preference?

ACP: We like entering a biotech (with no other marketed products) when it has first declared efficacy results; usually this is a Phase 2 trial. Before that, it is all unproven talk; after that, it is a crowd. A Phase 2 trial with solid efficacy results is the first time a new molecule comes out of the womb, so to say, and makes itself heard the right way. That’s the best time for a biotech professional to enter a speculative biotech. Someone who understands the science can make an educated guess about its prospects, but not everyone can do it, or has even heard of the company and/or the drug at this stage."

https://seekingalpha.com/article/4113055-will-biotech-continue-boom
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VKTX News